I have seen or heard, maybe on "Going Public", that no
CR envisaged until 2nd half 2025. Of course it is a
possibility that could change, however that is the spiel
at present. And does depend what revenue could occur
before then. As an earlier post mentioned if one platform
is given FDA approval for eg, bile duct cancer, which then
gives green light for use by oncologists in other cancers,
we will become a significantly better acquisition for BP
with CR not necessary.
Why IMU is a multi multi bagger, page-25651
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.4¢ | $890.8K | 19.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 176601 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 877572 | 7 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |